💊Pharma – News Releases

By FDA, Pharmaceutical

💊Pharma – News Releases

[Kyowa Hakko Kirin ]Kyowa Hakko Kirin Announces FDA Acceptance for Filing and Priority Review Designation of Mogamulizumab’s Biologics License Application

News Releases

http://www.kyowa-kirin.com/news_releases/2017/pdf/e20171128_02.pdf

BMS Newsroom

European Medicines Agency Validates Bristol-Myers Squibb’s Type II Variation Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) in Intermediate- and Poor-Risk Patients with Advanced Renal Cell Carcinoma

https://news.bms.com/press-release/bmy/european-medicines-agency-validates-bristol-myers-squibbs-type-ii-variation-applic

More from tokioX :

  1. 💉FDA PHARMA TODAY
  2. 💊FDA & PHARMA TODAY
  3. 💊FDA PHARMA TODAY
  4. 💊FDA PHARMA today
  5. 💊FDA PHARMA today
  6. 💊Kyowa Hakko Kirin, anti-Ccr4 humanized antibody acceptance application for European approval of Mogum Lysumab  20171027
  7. 💊Kyowa Hakko Kirin News、Ultragenyx and Kyowa Hakko Kirin Announce FDA Acceptance and Priority Review Designation of Burosumab’s Biologics License Application 20171010